These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7533690)

  • 1. Medical management of benign prostatic hypertrophy.
    Geller J
    Compr Ther; 1994; 20(12):682-7. PubMed ID: 7533690
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the best medical treatment for benign prostate hyperplasia?
    Evans MF; Frank J
    Can Fam Physician; 1997 Jun; 43():1073-4. PubMed ID: 9189295
    [No Abstract]   [Full Text] [Related]  

  • 3. [5-alpha reductase inhibitors plus alpha blockers. A combination therapy keeps a common disease checked].
    MMW Fortschr Med; 2003 Jul; 145(27-28):58-9. PubMed ID: 14587193
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical management of benign prostatic hyperplasia--are two drugs better than one?
    Vaughan ED
    N Engl J Med; 2003 Dec; 349(25):2449-51. PubMed ID: 14681512
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimising the medical management of benign prostatic hyperplasia.
    McDermott T
    Br J Clin Pract; 1997 Mar; 51(2):116-8. PubMed ID: 9158256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finasteride in benign prostatic hyperplasia.
    Verhamme KM; Bosch RJ; Sturkenboom MC
    N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15049034
    [No Abstract]   [Full Text] [Related]  

  • 7. [5-alpha reductase inhibitors or alpha blockers? The combination brakes best prostatic hyperplasia].
    MMW Fortschr Med; 2002 Oct; 144(44):56. PubMed ID: 12494605
    [No Abstract]   [Full Text] [Related]  

  • 8. [A trial of the use of finasteride and terazosin in patients with benign prostatic hyperplasia].
    Pushkar' DIu; Kosko DV; Loran OB; Kan IaD; Sapozhnikov IM; Tevlin KP
    Urol Nefrol (Mosk); 1995; (4):32-5. PubMed ID: 7571199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug treatment of benign prostatic hyperplasia].
    Schmid HP
    Praxis (Bern 1994); 1995 Sep; 84(39):1061-2. PubMed ID: 7481307
    [No Abstract]   [Full Text] [Related]  

  • 10. [The tested combination is recommended. Are 5-alpha reductase inhibitors interchangeable?].
    MMW Fortschr Med; 2003 Jul; 145(27-28):59. PubMed ID: 14587194
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical treatment of benign prostatic hyperplasia.
    Schmidt JD
    West J Med; 1991 Dec; 155(6):633. PubMed ID: 1725942
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of alpha-adrenergic inhibitors in treatment of benign prostatic hyperplasia and implications on sexual function.
    Kaplan SA
    Urology; 2004 Mar; 63(3):428-34. PubMed ID: 15028431
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficacy of finasteride in the treatment of hematuria associated with benign prostatic hypertrophy].
    Palou Redorta J; Gausa Gascon L; Salvador Bayarre J; Millán Rodríguez F; Segarra Tomás J; Villavicencio Mavrich H
    Arch Esp Urol; 2002 Oct; 55(8):895-9. PubMed ID: 12455279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical treatment as an alternative to surgery in the management of benign prostatic hypertrophy.
    Bredin HC
    Ir Med J; 1996; 89(3):86, 88. PubMed ID: 8707527
    [No Abstract]   [Full Text] [Related]  

  • 15. [Benign prostatic hyperplasia: medical therapy].
    Schlenker B; Gratzke C; Weidlich P; Seitz M; Reich O; Stief CG
    MMW Fortschr Med; 2007 Aug; 149(33-34):29-31; quiz 32. PubMed ID: 17912863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-surgical treatment of benign prostatic hypertrophy].
    Martini E; Vaggi L; Rucci A; Di Clemente L
    J Chir (Paris); 1994 Oct; 131(10):445-9. PubMed ID: 7532181
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological management of benign prostatic hyperplasia.
    Samkange C; Bhagat K
    Cent Afr J Med; 2000 Aug; 46(8):224-8. PubMed ID: 11317596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FPIN's clinical inquiries. Medical treatment of benign prostatic hyperplasia.
    Rich KT; Safranek S
    Am Fam Physician; 2008 Mar; 77(5):665-6. PubMed ID: 18350766
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prostatic adenoma: new drugs, new surgical techniques].
    Heinzl S
    Med Monatsschr Pharm; 1992 Dec; 15(12):362-4. PubMed ID: 1282201
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current state of the surgical treatment of benign prostatic hypertrophy].
    Pagano F
    J Urol (Paris); 1993; 99(6):362-3. PubMed ID: 7516392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.